Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Ischaemia-reperfusion injury renal

Jain S, Bicknell GR, Nicholson ML. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg 2000 87 1563-1568. [Pg.681]

Yoshioka etal. (1990) demonstrated enhancement of intrinsic antioxidant enzyme activity after renal ischaemia-reperfusion injury in the rat and protection of renal function against injuries induced by reactive oxygen species. [Pg.616]

PI (adenosine) receptors were explored as therapeutic targets before P2 receptors. Adenosine was identified early and is in current use to treat supraventricular tachycardia. A2a receptor antagonists are being investigated for the treatment of Parkinson s disease and patents have been lodged for the application of PI receptor subtype agonists and antagonists for myocardial ischaemia and reperfusion injury, cerebral ischaemia, stroke, intermittent claudication and renal insufficiency. [Pg.1052]

Ysebaert DK, DeGreef KE,Vercauteren SR,Ghielli M,Verpooten GA, Eyskens EJ, De Broe ME Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol.Dial.Transplant. 15 1562-1574,2000... [Pg.208]

See other pages where Ischaemia-reperfusion injury renal is mentioned: [Pg.85]    [Pg.87]    [Pg.87]    [Pg.89]    [Pg.91]    [Pg.92]    [Pg.93]    [Pg.95]    [Pg.329]    [Pg.87]    [Pg.88]    [Pg.363]   
See also in sourсe #XX -- [ Pg.88 , Pg.89 , Pg.90 ]



SEARCH



Ischaemia

Ischaemia reperfusion

Renal injury

Reperfusion

© 2024 chempedia.info